• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
.[J].Journal Of Pharmaceutical Research,2020,39(1):1-6[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3432times   Download 3302次 QR Code for this article
Scan with your phone!
卡托普利:从多肽到小分子降血压药物的研发历程
文雨,刘健,胡立宏
Font:Larger+|Default|Smaller-
(南京中医药大学药学院中药功效物质重点实验室,江苏 南京 210023)
摘要:
关键词:  卡托普利  血管紧张素转化酶抑制剂  高血压
DOI:10.13506/j.cnki.jpr.2020.01.001
基金项目:江苏省研究生科研与实践创新计划项目(No.SJCX18_0448);国家自然科学基金青年基金项目(No.81703342);国家自然科学基金面上项目(No.81773596);江苏省自然科学青年基金项目(No.BK2016105)
()
Abstract:
Key words:  
Today's Visits:527    Total Visits:2383269
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.